Genes and susceptible loci of Alzheimer's disease

Brain Research Bulletin

Volumn 48, Issue 2, 1999, Pages 121-127

  Shastry, Barkur S ^a   Giblin, Frank J ^a  

^a OAKLAND UNIVERSITY   (United States)

Author keywords

Amyloid; Autosomal dominant; Presenilins; Transgenic mice

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; APOLIPOPROTEIN E; PRESENILIN 1; PRESENILIN 2;

ALZHEIMER DISEASE; GENE LOCUS; GENETIC SUSCEPTIBILITY; HUMAN; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRANSGENIC MOUSE;

ALZHEIMER DISEASE; AMINO ACID SEQUENCE; ANIMALS; HUMANS; MOLECULAR SEQUENCE DATA;

EID: 0033555298     PISSN: 03619230     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0361-9230(98)00156-7     Document Type: Review

References (86)

1. Bales, K. R.; Verina, T.; Dodel, R. C.; Du, Y.; Altstiel, L.; Bender, M.; Hyslop, P.; Johnstone, E. M.; Little, S. P.; Cummins, D. J.; Piccardo, P.; Ghetti, B.; Paul, S. M. Lack of apolipoprotein E dramatically reduces amyloid ß peptide deposition. Nat. Genet. 17:263-264; 1997.
2. Blacker, D.; Tanzi, R. E. The genetics of Alzheimer disease. Arch. Neurol. 55:294-296; 1998.
3. Blacker, D.; Wilcox, M. A.; Laird, N. M.; Rodes, L.; Horvath, S. M.; Go, R. C. P.; Perry, R.; Watson, Jr., B.; Bassett, S. S.; McInnis, M. G.; Albert, M. S.; Hyman, B. T.; Tanzi, R. E. Alpha-2 microglobulin is genetically associated with Alzheimer disease. Nat. Genet. 19:357-360; 1998.
4. Blanc, E.; Toborex, M.; Mark, R.; Matton, M. Amyloid β-peptide disrupts barrier and transport functions and induces apoptosis in vascular endothelial cells. J. Neurochem. 68:1870-1881; 1997.
5. Botto, M.; Hawkins, P. N.; Bickerstaff, M. C. M.; Herbert, J.; Bygrave, A. E.; McBride, A.; Hutchinson, W. L.; Tennent, G. A.; Walport, M. J.; Pepys, M. B. Amyloid deposition is delayed in mice with targeted deletion of the serum amyloid P component gene. Nat. Med. 4:855-859; 1997.
6. Cook, D. G.; Forman, M. S.; Sung, J. C.; Leight, S.; Kolson, D. L.; Iwatsubo, T.; Lee, V. M.-Y.; Doms, R.W. Alzheimer Aβ (1-42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells. Nat. Med. 3:1021-1023; 1997.
7. Crook, R.; Verkkoniemi, A.; Perez-Tur, J.; Mehta, N.; Baker, M.; Houlden, H.; Farrer, M.; Hutton, M.; Lincoln, S.; Hardy, J.; Gwinn, K.; Somer, M.; Paetau, A.; Kalimo, H.; Ylikoski, R.; Poyhonen, M.; Kucera, S.; Haltia, M. A variant of Alzheimer disease with spastic paraparesis and unusual plaques due to deletion of exon-9 of presenilin 1. Nat. Med. 4:452-455; 1998.
8. Cruts, M.; Hendriks, L.; Van Broeckhoven, C. The presenilin genes: A new gene family involved in Alzheimer disease pathology. Hum. Mol. Genet. 5:1449-1455; 1996.
9. Cruts, M.; Backhovens, H.; Wang, S. Y.; Van Gassen, G.; Gheuens, J.; De Jonghe, C.; Wehnert, A.; De Voecht, J.; De Winter, G.; Cras, P.; Bruyland, M.; Datson, N.; Weissenbach, J.; den Dunnen, J. T.; Martin, J.J.; Hendriks, L.; Van Broekhoven, C. Molecular genetics analysis of familial early-onset Alzheimer disease linked to chromosome 14q24.3. Hum. Mol. Genet. 4:2363-2371; 1995.
10. Davis, R. E.; Miller, S.; Herrnstadt, C.; Ghosh, S. S.; Fahy, E.; Shinobu, L. A.; Galasko, D.; Thal, L. J.; Beal, M. F.; Howell, N.; Parker, Jr., W.D. Mutations in mitochondrial cytochrome c oxidase genes segregate with late-onset Alzheimer disease. Proc. Nat. Acad. Sci. USA 94:4526-4531; 1997.
11. DebBurman, S. K.; Raymond, G. J.; Caughey, B.; Lindquist, S. Chaperone-supervised conversion of prion protein to its protease resistant form. Proc. Nat. Acad. Sci. USA 94:13938-13943; 1997.
12. Dickson, D. W.; Crystal, H. A.; Mattiace, L. A.; Masur, D. M.; Blau, A. D.; Davies, P.; Yeu, S. H.; Aronson, M. K. Identification of normal and pathological aging in prospectively studied non-demented elderly humans. Neurobiol. Aging 13:179-189; 1991.
13. Enserink, M. First Alzheimer diagnosis confirmed. Science 279:2037; 1998.
14. Evans, D. A.; Beckett, L. A.; Field, T. S.; Feng, L.; Albert, M. S.; Bennett, D. A.; Tycko, B.; Mayeux, R. Apolipoprotein E E4 and incidence of Alzheimer disease in a community population of older persons. J. Am. Med. Assoc. 277:822-824; 1997.
15. Games, D.; Adams, D.; Alessandrinl, R.; Barbour, R.; Berthelette, P.; Blackwell, C.; Carr, T.; Clemens, J.; Donaldson, T.; Gillespie, F.; Guido, F. T.; Hagoplan, S.; Johnson-Wood, K.; Khan, K.; Lee, M.; Lebowitz, E.; McConlogue, S.; Montoya-Zarala, M.; Mucke, L.; Paganini, L.; Penniman, E.; Power, M.; Schenk, D.; Seubert, P.; Snyder, B.; Soriano, F.; Tan, H.; Vitale, J.; Wadsworth, S.; Wolozin, B.; Zhao, J. Alzheimer type neuropathology in transgenic mice overexpressing V717F β amyloid precursor protein. Nature 373:523-527; 1995.
16. Geula, C.; Wu, C.-K.; Saroff, D.; Lorenzo, A.; Yuan, M.; Yankner, B. A. Aging renders the brain vulnerable to amyloid β-protein neurotoxicity. Nat. Med. 4:827-831; 1998.
17. Guo, Q.; Christakos, S.; Robinson, N.; Mattson, M. P. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function. Proc. Nat. Acad. Sci. USA 95:3227-3232; 1998.
18. Guo, Q.; Fu, W.; Xie, J.; Luo, H.; Sells, S. F.; Geddes, J.W.; Bondada, V.; Rangnekar, V. M.; Mattson, M. P. Par-4 is a mediator of neuronal degeneration associated with the pathogenesis of Alzheimer disease. Nat. Med. 4:957-962; 1998.
19. Guo, Q.; Sopher, B. L.; Furukawa, K.; Pham, D. G.; Robinson, N.; Martin, G. M.; Mattson, M. P. Alzheimer's presenilin mutation sensitizes neural cells to apoptosis induced by trophic factor withdrawal and amyloid β-peptide: Involvement of calcium and oxyradicals. J. Neurosci. 17: 4212-4222; 1997.
20. Haass, C. Presenilins: Genes for life and death. Neuron 18:687-690; 1997.
21. Hardy, J. Amyloid, the presenilins and Alzheimer disease. Trends Neurosci. 20:154-159; 1997.
22. Hardy, J. The Alzheimer family of diseases. Many etiologies one pathogenesis. Proc. Nat. Acad. Sci. USA 94:2095-2097; 1997.
23. Hartmann, T.; Bieger, S. C.; Bruhl, B.; Tienari, P. J.; Ida, N.; Allsop, D.; Roberts, G. W.; Masters, C. L.; Dotti, C. G.; Unsicker, K.; Beyreuther, K. Distinct sites of intracellular production of Alzheimer disease Aβ40/42 amyloid peptides. Nat. Med. 3:1016-1020; 1997.
24. Hartmann, H.; Busciglio, J.; Baumann, K.-H.; Staufenbiel, M.; Yankner, B. A. Developmental regulation of presenilin-1 processing in the brain suggests a role in neuronal differentiation. J. Biol. Chem. 272:14505-14508; 1997.
25. Heintz, N.; Zoghbi, H. α-synuclein - A link between Parkinson and Alzheimer diseases. Nat. Genet. 16:325-327; 1997.
26. Houlden, H.; Crook, R.; Backhovens, H.; Prihar, G.; Baker, M.; Hutton, M.; Rossor, M.; Martin, J. J.; Van Broeckhoven, C.; Hardy, J. APOE genotype is a risk factor in non-presenilin early-onset Alzheimer disease families. Am. J. Med. Genet. 81:117-121; 1998.
27. Hsiao, K.; Borchel, T.; Olson, K.; Johannsdottir, R.; Kitt, C.; Yunis, W.; Xu, S.; Eckman, C.; Younkin, S.; Price, D. Age-related CNS disorder and early death in transgenic FVB/N mice overexpressing Alzheimer amyloid precursor protein. Neuron 15:1203-1218; 1995.
28. Hsiao, K.; Chapman, P.; Nilsen, S.; Eckman, C.; Harigaya, Y.; Younkin, S.; Yang, F.; Cole, G. Correlative memory deficits, Aβ elevation and amyloid plaques in transgenic mice. Science 274:99-103; 1996.
29. Hutchin, T. P.; Heath, P. R.; Pearson, R. C. A.; Sinclair, A. J. Mitochondrial DNA mutations in Alzheimer disease. Biochem. Biophys. Res. Comm. 241:221-225; 1997.
30. Hutton, M.; Hardy, J. The presenilins and Alzheimer disease. Hum. Mol. Genet. 6:1639-1646; 1997.
31. I-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393:702-705; 1998.
32. Johnson-Wood, K.; Lee, M.; Motter, K.; Hu, G.; Gordon, R.; Barbour, K.; Gordon, H.; Tan, H.; Games, D.; Lieberburg, I.; Schenk, D.; Seubert, P.; McConlogue, L. Amyloid precursor protein processing and Aβ42 deposition in a transgenic mouse model of Alzheimer disease. Proc. Nat. Acad. Sci. USA 94:1550-1555; 1997.
33. Katzman, R.; Terry, R.; DeTeresa, R.; Brown, T.; Davis, P.; Flud, P.; Renbing, X.; Peck, A. Clinical, pathological and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques. Ann. Neurol. 23:138-144; 1988.
34. Keller, J. F.; Pang, Z.; Geddes, J. W.; Begley, J. G.; Germeyer, A.; Waeg, G.; Matton, M. P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and disfunction in synaptosomes by amyloid β-peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:273-284; 1997.
35. Kelly, J. F.; Furukawa, K.; Barger, S. W.; Rengen, M. R.; Mark, R. J.; Blanc, E. M.; Roth, G.S.; Mattson, M. P. Amyloid β-peptide disrupts carbachol-induced muscarinic cholinergic signal transduction in cortical neurons. Proc. Nat. Acad. Sci. USA 93:6753-6758; 1996.
36. Kim, T.-W.; Tanzi, R. E. Presenilins and Alzheimer disease. Curr. Opin. Neurobiol. 7:683-688; 1997.
37. Lambert, J. C.; Waurant-DeVizieze, F.; Amouyel, P.; Chartier-Harlin, M. C. Association at LRP gene locus with sporadic late-onset Alzheimer disease. Lancet 351:1787-1788; 1998.
38. Lassman, H., Bancher, C., Breitschopf, H., Wegiel, J., Bobinski, M., Jellinger, K., Wisniewski, H. M. Cell death in Alzheimer disease evaluated by DNA fragmentation in situ. Acta Neuropathol. 89:35-41; 1995.
39. Lehmann, S.; Chiesa, R.; Harris, D. A. Evidence for six-transmembrane domain structure of presenilin 1. J. Biol. Chem. 272:12047-12051; 1997.
40. Lemere, C. A.; Popera, F.; Kosik, K. S.; Lendon, C. L.; Ossa, J.; Saido, T. C.; Yamaguchi, H.; Ruiz, A.; Martinez, A.; Madrigal, L.; Hincapie, L.; Arango, J. C.; Anthony, D. C.; Koo, E. H.; Goate, A. M.; Selkoe, D. J.; Arango, J. C. The E280A presenilin-1 Alzheimer mutation produces increased Aβ42 deposition and severe cerebellar pathology. Nat. Med. 2:1146-1150; 1996.
41. Lendon, C. L.; Ashall, F.; Goate, A. M. Exploring the etiology of Alzheimer disease using molecular genetics. J. Am. Med. Assoc. 277:825-831; 1997.
42. Levitan, D.; Doyle, T. G.; Brousseau, D.; Lee, M. K.; Thinakaran, G.; Slunt, H. H.; Sisodia, S. S.; Greenwald, I. Assessment of normal and mutant human presenilin function in Caenorhabditis elegans. Proc. Nat. Acad. Sci. USA 93:14940-14944; 1996.
43. Lopera, F.; Ardilla, A.; Martinez, A.; Madrigal, L.; Arango-Viana, J. C.; Lemere, C. A.; Arango-Lasprilla, J.C.; Hincapie, L.; Arcos-Burgos, M.; Ossa, J. E.; Behrens, I. M.; Norton, J.; Lendon, C.; Goate, A. M.; Ruiz-Linares, A.; Rosselli, M.; Kosik, K. S. Clinical features of early-onset Alzheimer disease in a large kindred with an E280A presenilin-1 mutation. J. Am. Med. Assoc. 277:793-799; 1997.
44. 2+ homeostasis and cell death. J. Neurosci. 15: 6239-6249; 1995.
45. Mark, R. J.; Pang. Z.; Geddes, J. W.; Uchida, K.; Mattson. M. P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J. Neurosci. 17:1046-1054; 1997
46. Masters, C. L.; Beyreuther, K. Alzheimer disease. Br. Med. J. 316: 446-448; 1998.
47. Mattson, M. P. Advances fuel Alzheimer conundrum. Nat. Genet. 17:254-256; 1997.
48. Mattson, M. P. Cellular actions of the β-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77:1081-1132; 1997.
49. Maury, C. P. J.; Nurmiaho-Lassila, E.-L.; Liljestrom, M. Alzheimer disease - Associated presenilins 1 and 2: Accelerated amyloid fibril formation of mutant 410 Cysto Tyr and 141 Asn to He peptides. Biochem. Biophys. Res. Comm. 235:249-252; 1997.
50. Montoya, S. E.; Aston, C. E.; Dekosky, S. T.; Kamboh, M. I.; Lazo, J. S.; Ferrell, R. E. Bleomycin hydrolase is associated with risk of sporadic Alzheimer disease. Nat. Genet. 18:211-212; 1998.
51. Muller, U.; Cristina, N.; Li, Z.-W.; Wolfer, D. P.; Lipp, H.-P.; Rulicke, T.; Branduer, S.; Aguzzi, A.; Weissman, C. Behavioral and anatomical deficits in mice homozygous for a modified β-amyloid precursor gene. Cell 79:755-765; 1994.
52. Nalbantoglu, J.; Tirado-Santiago, G.; Lahsaini, A.; Poirier, J.; Goncalves, O.; Verge, G.; Momoli, F.; Welner, S. A.; Massicotte, G.; Julien, J.-P.; Shapiro, M. L. Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature 387:500-505; 1997.
53. Pearson, R. C. A.; Esiri, M. M.; Hiorns, R. W.; Wilcock, G. K.; Powell, T. P. S. Anatomical correlates of the distribution of the pathological changes in the cortex in the Alzheimer disease. Proc. Nat. Acad. Sci. USA 82:4531-4534; 1985.
54. Pericak-Vance, M. A.; Bass, M. P.; Yamaoka, L. H.; Gaskell, P. C.; Scott, W. K.; Terwedow, H. A.; Menold, M. M.; Conneally, P. M.; Small, G. W.; Vance, J. M.; Saunders, A. M.; Roses, A. D.; Haines, J. L. Complete genomic screen in late-onset familial Alzheimer disease. J. Am. Med. Assoc. 278:1237-1241; 1997.
55. Roses, A. D. Genetic testing for Alzheimer disease. Arch. Neurol. 54:1226-1229; 1997.
56. Roses, A. D. Alzheimer diseases. Am. J. Med. Genet. 81:49-57; 1998.
57. Schellenberg, G. D. Genetic dissection of Alzheimer diseases, a heterogeneous disorder. Proc. Nat. Acad. Sci. USA 92:8552-8559; 1995.
58. Scheuner, D.; Eckman, C.; Jensen, M.; Song, X.; Citron, M.; Suzuki, N.; Bird, T. D.; Hardy, J.; Hutton, M.; Kukull, W.; Larson, E.; Levy-Lahad, E.; Viitanen, M.; Peskind, E.; Poorkaj, P.; Schellenberg, G.; Tanzi, R.; Wasco, W.; Lannfelt, L.; Selkoe, D. J.; Younkin, S. Secreted amyloid β protein similar to that in the senile plaques of Alzheimer disease is increased in vivo by the presenilin 1 and 2 and APP mutations linked to familial Alzheimer disease. Nat. Med. 2:864-870; 1996.
59. Schirmer. E. C.; Lindquist, S. Interactions of the chaperone HSP104 with yeast sup35 and mammalian PrP. Proc. Nat. Acad. Sci. USA 94:13932-13937; 1997.
60. Schmechel, D. E.; Saunders, A. M.; Strittmatter, W. J.; Crain, B. J.; Hulette, C. M.; Joo, S. H.; Pericak-Vauce, M. A.; Goldgaber, D.; Roses, A. D. Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Nat. Acad. Sci. USA 90:9649-9653; 1993.
61. Schmidt, M. L.; Lee, V. M.-Y.; Forman, M.; Chiu, T.-S.; Trojanowski, J. Q. Monoclonal antibodies to a 100-kd protein reveal abundant Aβ-negative plaques throughout gray matter of Alzheimer disease brains. Am. J. Pathol. 151:69-80; 1997.
62. Schweers, O.; Mandelkow, E.-M.; Biermat, J.; Mandelkow, E. Oxidation of cysteine 322 in the repeat domain of microtubule associated protein tau controls the in vitro assembly of paired helical filaments. Proc. Nat. Acad. Sci. USA 92:8463-8467; 1995.
63. Selkoe, D. J. Amyloid β-protein and the genetics of Alzheimer disease. J. Biol. Chem. 271:18295-18298; 1996.
64. Selkoe, D. J. Amyloid β-protein precursor: New clues to the genesis of Alzheimer disease. Curr. Opin. Neurobiol. 4:708-716; 1994.
65. Shastry, B. S. Molecular genetics of familial Alzheimer disease. Am. J. Med. Sci. 315:266-272; 1998.
66. Shen, J.; Bronson, R. T.; Chen, D. F.; Xia, W.; Selkoe, D. J. E.; Tonegawa, S. Skeletal and CNS defects in presenilin-1-deficient mice. Cell 89:629-639; 1997.
67. Slooter, A. J. C.; Tang, M.-X.; Van Duijn, C. M.; Stern, Y.; Ott, A.; Bell, K.; Breteler, M. M. B.; Van Broeckhoven, C.; Tatemichi, T. K.; Tycko, B.; Hofman, A.; Mayeux, R. Apolipoprotein E E4 and the risk of dementia with stroke. J. Am. Med. Assoc. 277:818-821; 1997.
68. Smith, M. A.; Rudnicka-Nawrot, M.; Lrichey, P. L.; Praprotnik, D.; Mulrihill, P.; Miller, C. A.; Sayre, L. M.; Perry, G. Carbonyl-related posttranslational modification of neurofilament protein in the neurofibrillary pathology of Alzheimer disease. J. Neurochem. 64:2660-2666; 1995.
69. Soto, C.; Sigurdsson, E. M.; Morelli, L.; Kumar, R. A.; Castano, R. M.; Frangione, B. β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implication for Alzheimer therapy. Nat. Med. 4:822-826; 1998.
70. Strittmatter, W. J.; Saunders, A. M.; Goedert, M.; Weisgraber, K. H.; Dong, L.-M.; Jakes, R.; Huang, D. Y.; Pericak-Vance, M.; Schmechel, D.; Roses A. D. Isoform specific interactions of apolipoprotein E with microtubule associated protein tau: Implications for Alzheimer disease. Proc. Nat. Acad. Sci. USA 91:11183-11186; 1994.
71. Su, J. H.; Anderson, A. J.; Cummings, B.; Cotman, C. W. Immunocytochemical evidence for apoptosis in Alzheimer disease. Neuroreport 5:2529-2533; 1994.
72. Talamo, B. R.; Rudel, R. A.; Kosik, K. S. M-Y.; Lee, V.; Neff, S.; Adelman, L.; Kauer, J. S. Pathological changes in the olfactory neurons in patients with Alzheimer disease. Nature 337:736-739; 1989.
73. Tang, M.-X.; Stern, Y.; Marder, K.; Bell, K.; Gurland, B.; Lantigua, R.; Andrews, H.; Feng, L.; Tycko, B.; Mayeux, R. The APOE epsilon 4 allele and the risk of Alzheimer disease among African Americans, Whites and Hispanics. J. Am. Med. Assoc. 279:751-755; 1998.
74. Tomita, T.; Maruyama, K.; Saido, T. C.; Kume, H.; Shinozaki, K.; Tokuhiro, S.; Capell, A.; Walter, J.; Grunberg, J.; Haass, C.; Iwatsubo, T.; Obata, K. The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid β protein ending at the 42nd (or 43rd) residue. Proc. Nat. Acad. Sci. USA 94:2025-2030; 1997.
75. Trojanowski, J. Q.; Lee, M.-Y. Aggregation of neurofilament and α-synuclein proteins in Lewy bodies. Arch. Neurol. 55:151-152; 1998.
76. Van Broeckhoven, C. Presenilins and Alzheimer disease. Nat. Genet. 11:230-232; 1995.
77. Van Leeuwen, F. W.; Dekleijn, D. P. V.; Van den Hurk, H. H.; Neubauer, A.; Sonnemans, M. A. F.; Sluijs, J. A.; Koycu, S.; Ramdjielal, R. D. J.; Salehi, A.; Martens, G. J. M.; Grosueld, F. G.; Burbach, J. P. H.; Hol, E. M. Frameshift mutant of β amyloid precursor protein and ubiquitin-B in Alzheimer and Down patients. Science 279:242-247; 1998.
78. Wong, P. C.; Zheng, H.; Chen, H.; Becher, M. W.; Sirinathsinghji, D. J. S.; Trumbauer, M. E.; Chen, H. Y.; Price, D. L.; Van der Ploeg, L. H. T.; Sisodia, S. S. Presenilin 1 is required for Notch 1 and Dll 1 expression in the paraxial mesoderm. Nature 387:288-292; 1997.
79. Wragg, M.; Hutton, M.; Talbot, C. Genetic association between intronic polymorphism in presenilin-1 gene and late-onset Alzheimer disease. Lancet 347:509-512; 1996.
80. Xia, W.; Zhang, J.; Perez, R.; Koo, E. H.; Selkoe, D. J. Interaction between amyloid precursor protein and presenillins in mammalian cells: Implications for the pathogenesis of Alzheimer disease. Proc. Nat. Acad. Sci. USA 94:8208-8213; 1997.
81. Yaar, M.; Zhai, S.; Pilch, P. F.; Doyle, S. M.; Eisenhauer, P. B.; Fine, R. E.; Gilchrest, B. A. Binding of β amyloid to the p75 neurotrophin receptor induces apoptosis. J. Clin. Invest. 100:2333-2340; 1997.
82. Yankner, B. A. Mechanisms of neuronal degeneration in Alzheimer disease. Neuron 16: 921-932; 1996.
83. Yau, S. D.; Fu, J.; Soto, C.; Chen, X.; Zhu, H.; Al-Mohanna, F.; Collison, K.; Zhu, A.; Stern, E.; Saido, T.; Tohyama, M.; Ogawa, S.; Roher, A.; Stern, D. An intracellular protein that binds amyloid β peptide and mediates neurotoxicity in Alzheimer disease. Nature 389: 689-695; 1997.
84. Zheng, H.; Jiang, M.; Trumbauer, M. E.; Sirinathsinghji, D. J. S. ; Hopkins, R.; Smith, D. W.; Heavens, R. P.; Conner, M. W.; Stevens, K. A.; Slunt, H. H.; Sisodia, S. S.; Chen, H. Y.; Van der ploeg, L. H. J. β-amyloid precursor protein deficient mice show reactive gliosis and decreased locomotor activity. Cell 81:525-531; 1995.
85. Zubenko, G. S.; Hughes, H. B.; Stiffler, J. S.; Hurtt, M. R.; Kaplan, B. B. A genome survey for novel Alzheimer disease risk loci: Results at 10-cM resolution. Genomics 50:121-128; 1998.
86. Zubenko, G. S.; Stiffler, J. S.; Hughes, H. B.; Hurtt, M. R.; Kaplan, B. B. Initial results of a genome survey for Novel Alzheimer disease risk genes. Am. J. Med. Genet. 81:196-205; 1998.